Kinamed

Executive Summary

Kinamed is a privately-held medical device company based in Camarillo, California, founded in 1993. The company specializes in orthopedic, cardiothoracic, and neurosurgical implants and instrumentation, with a focus on polymer-based cerclage cables and bone preparation systems. Kinamed's core value proposition is to enhance implant fixation strength and durability while mitigating complications such as metal debris generation. By leveraging advanced materials and innovative designs, the company aims to improve surgical outcomes and patient recovery. Although Kinamed operates in a competitive med-tech landscape, its niche focus on polymer solutions differentiates it from traditional metal-based implant manufacturers. The company has a long history of innovation but remains private, with no disclosed funding rounds or revenue figures. Key growth drivers include increasing demand for minimally invasive surgeries and the rising prevalence of orthopedic conditions in an aging population. Kinamed's product portfolio addresses unmet needs in joint reconstruction, spine surgery, and trauma care. The company's private status limits visibility into its financial performance, but its sustained presence since 1993 suggests a stable business model. Future success hinges on expanding market adoption of its polymer cerclage systems and securing regulatory clearances for new applications. Overall, Kinamed represents a mature but niche player in the medical device industry, with opportunities for growth if it can capitalize on trends toward biocompatible and debris-reducing implant technologies.

Upcoming Catalysts (preview)

• Q4 2026FDA 510(k) clearance for next-generation polymer cerclage system70% success
• Q2 2026Strategic partnership or distribution agreement for European market expansion50% success
• Q3 2026Publication of positive clinical outcomes for polymer cables in revision hip surgery60% success